Naslov
High-throughput and site-specific N- glycosylation analysis of human alpha-1-acid glycoprotein offers a great potential for new biomarker discovery

Autori
Keser, Toma ; Tijardović, Marko ; Gornik, Ivan ; Lukić, Edita ; Lauc, Gordan ; Gornik, Olga ; Novokmet, Mislav

Izvornik
Molecular & cellular proteomics (1535-9476) 20 (2021); 100044, 15

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
alpha-1-acid glycoprotein ; glycosylation ; high-throughput ; biomarker ; type 2 diabetes

Sažetak
Alpha-1-acid glycoprotein (AGP) is an acute phase glycoprotein in blood, which is primarily synthetized in the liver and whose biological role is not completely understood. It consists of 45% carbohydrates that are present in the form of five N-linked complex glycans. AGP N- glycosylation was shown to be changed in many different diseases, and some changes appear to be disease-specific ; thus, it has a great diagnostic and prognostic potential. However, AGP glycosylation was mainly analyzed in small cohorts and without detailed site-specific glycan information. Here, we developed a cost- effective method for a high- throughput and site-specific N-glycosylation LC-MS analysis of AGP which can be applied on large cohorts, aid in search for novel disease biomarkers, and enable better understanding of AGP’s role and function in health and disease. The method does not require isolation of AGP with antibodies and affinity chromatography, but AGP is enriched by acid precipitation from 5 μl of bloodplasma in a 96-well format. After trypsinization, AGP glycopeptides are purified using a hydrophilic interaction chromatography- based solid-phase extraction and analyzed by reversed-phase-liquid chromatography- electrospray ionization-MS. We used our method to show for the first time that AGP N-glycan profile is stable in healthy individuals (14 individuals in three time points), which is a requirement for evaluation of its diagnostic potential. Furthermore, we tested our method on a population including individuals with registered hyperglycemia in critical illness (59 cases and 49 controls), which represents a significantly increased risk of developing type 2 diabetes. Individuals at higher risk of diabetes presented increased N-glycan branching on AGP’s second glycosylation site and lower sialylation of N-glycans on AGP’s third and AGP1’s fourth glycosylation site. Although this should be confirmed on a larger prospective cohort, it indicates that site-specific AGP N- glycan profile could help distinguish individuals who are at risk of type 2 diabetes.

Izvorni jezik
Engleski

Znanstvena područja
Farmacija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)

POVEZANOST RADA